{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:49:43Z","timestamp":1793202583455,"version":"4.5.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012304","name":"School of Medicine, Johns Hopkins University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["andjrnl.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Academy of Nutrition and Dietetics"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jand.2019.05.015","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T08:19:56Z","timestamp":1566980396000},"page":"565-586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":208,"title":["Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies"],"prefix":"10.1016","volume":"120","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuha","family":"Alammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajdeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Nanavati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard E.","family":"Mullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1016\/j.jand.2019.05.015_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41395-018-0084-x","article-title":"American College of Gastroenterology monograph on management of irritable bowel syndrome","volume":"113","author":"Ford","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jand.2019.05.015_bib2","first-page":"71","article-title":"The epidemiology of irritable bowel syndrome","volume":"6","author":"Canavan","year":"2014","journal-title":"Clin Epidemiol"},{"issue":"37","key":"10.1016\/j.jand.2019.05.015_bib3","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.3748\/wjg.v18.i37.5151","article-title":"Irritable bowel syndrome: Diagnosis and pathogenesis","volume":"18","author":"El-Salhy","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.jand.2019.05.015_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11894-017-0554-0","article-title":"Update on Rome IV Criteria for colorectal disorders: Implications for clinical practice","volume":"19","author":"Simren","year":"2017","journal-title":"Curr Gastroenterol Rep"},{"issue":"40","key":"10.1016\/j.jand.2019.05.015_bib5","doi-asserted-by":"crossref","first-page":"11353","DOI":"10.3748\/wjg.v21.i40.11353","article-title":"Genetic epidemiology of irritable bowel syndrome","volume":"21","author":"Makker","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jand.2019.05.015_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrgastro.2016.191","article-title":"The mucosal immune system: Master regulator of bidirectional gut-brain communications","volume":"14","author":"Powell","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jand.2019.05.015_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/bs.vh.2016.09.005","article-title":"The place of stress and emotions in the irritable bowel syndrome","volume":"103","author":"Pellissier","year":"2017","journal-title":"Vitam Hormon"},{"issue":"1","key":"10.1016\/j.jand.2019.05.015_bib8","first-page":"29","article-title":"Irritable bowel syndrome and visceral hypersensitivity: Risk factors and pathophysiological mechanisms","volume":"79","author":"Deiteren","year":"2016","journal-title":"Acta Gastroenterol Belg"},{"issue":"2","key":"10.1016\/j.jand.2019.05.015_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.gtc.2005.02.010","article-title":"Disturbances of motility and visceral hypersensitivity in irritable bowel syndrome: Biological markers or epiphenomenon","volume":"34","author":"Quigley","year":"2005","journal-title":"Gastroenterol Clin North Am"},{"issue":"7","key":"10.1016\/j.jand.2019.05.015_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/0148607114545329","article-title":"Irritable bowel syndrome: Contemporary nutrition management strategies","volume":"38","author":"Mullin","year":"2014","journal-title":"JPEN"},{"issue":"8","key":"10.1016\/j.jand.2019.05.015_bib11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/PSY.0000000000000470","article-title":"Understanding the gut microbiota in inflammatory and functional gastrointestinal diseases","volume":"79","author":"Sundin","year":"2017","journal-title":"Psychosom Med"},{"issue":"2","key":"10.1016\/j.jand.2019.05.015_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/cns.12490","article-title":"Stress and the microbiota-gut-brain axis in visceral parelevance to irritable bowel syndrome","volume":"22","author":"Moloney","year":"2016","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"10.1016\/j.jand.2019.05.015_bib13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/jgh.13417","article-title":"Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome","volume":"32","author":"Gonzalez-Castro","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jand.2019.05.015_bib14","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.14592.1","article-title":"The gut microbiome and irritable bowel syndrome","volume":"7","author":"Menees","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.jand.2019.05.015_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/164_2016_115","article-title":"The role of the gastrointestinal microbiota in visceral pain","volume":"239","author":"Rea","year":"2017","journal-title":"Handb Exp Pharmacol"},{"issue":"3","key":"10.1016\/j.jand.2019.05.015_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000447252","article-title":"Increased intestinal permeability and decreased barrier function: Does it really influence the risk of inflammation?","volume":"1","author":"Fukui","year":"2016","journal-title":"Inflamm Intest Dis"},{"issue":"3","key":"10.1016\/j.jand.2019.05.015_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrgastro.2010.4","article-title":"Pathogenesis of IBS: Role of inflammation, immunity and neuroimmune interactions","volume":"7","author":"Ohman","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jand.2019.05.015_bib18","first-page":"14","article-title":"Interaction between the gut microbiome and mucosal immune system","volume":"4","author":"Shi","year":"2017","journal-title":"Mil Med Res"},{"issue":"6","key":"10.1016\/j.jand.2019.05.015_bib19","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/gutjnl-2017-313713","article-title":"Incidence of irritable bowel syndrome and chronic fatigue following GI infection: A population-level study using routinely collected claims data","volume":"67","author":"Donnachie","year":"2018","journal-title":"Gut"},{"issue":"3-4","key":"10.1016\/j.jand.2019.05.015_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10354-017-0592-0","article-title":"Intestinal microbiome-gut-brain axis and irritable bowel syndrome","volume":"168","author":"Moser","year":"2018","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.jand.2019.05.015_bib21","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1572-0241.2006.00654.x","article-title":"Postinfectious irritable bowel syndrome\u2014A meta-analysis","volume":"101","author":"Halvorson","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jand.2019.05.015_bib22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00535-018-1476-9","article-title":"Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: A systematic review and meta-analysis","volume":"53","author":"Chen","year":"2018","journal-title":"J\u00a0Gastroenterol"},{"issue":"4","key":"10.1016\/j.jand.2019.05.015_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002534","article-title":"Rifaximin for irritable bowel syndrome: A meta-analysis of randomized placebo-controlled trials","volume":"95","author":"Li","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.jand.2019.05.015_bib24","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/ajg.2014.202","article-title":"Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: Systematic review and meta-analysis","volume":"109","author":"Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jand.2019.05.015_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12876-016-0470-z","article-title":"Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: A meta-analysis","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"10.1016\/j.jand.2019.05.015_bib26","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13170","article-title":"Potential mechanisms of effects of serum-derived bovine immunoglobulin\/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome","volume":"5","author":"Valentin","year":"2017","journal-title":"Physiol Rep"},{"issue":"5","key":"10.1016\/j.jand.2019.05.015_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/17474124.2018.1447380","article-title":"Fecal microbiota transplantation for managing irritable bowel syndrome","volume":"12","author":"El-Salhy","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jand.2019.05.015_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ismej.2007.3","article-title":"Long-term ecological impacts of antibiotic administration on the human intestinal microbiota","volume":"1","author":"Jernberg","year":"2007","journal-title":"ISME J"},{"key":"10.1016\/j.jand.2019.05.015_bib29","author":"Mullin"},{"issue":"7","key":"10.1016\/j.jand.2019.05.015_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"issue":"15","key":"10.1016\/j.jand.2019.05.015_bib31","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jand.2019.05.015_bib32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.jand.2019.05.015_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"issue":"11","key":"10.1016\/j.jand.2019.05.015_bib34","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"7626","key":"10.1016\/j.jand.2019.05.015_bib35","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bmj.39343.408449.80","article-title":"Uncertainty in heterogeneity estimates in meta-analyses","volume":"335","author":"Ioannidis","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.jand.2019.05.015_bib36","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","year":"2011"},{"key":"10.1016\/j.jand.2019.05.015_bib37","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"issue":"7109","key":"10.1016\/j.jand.2019.05.015_bib38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"20","key":"10.1016\/j.jand.2019.05.015_bib39","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1002\/sim.6525","article-title":"Publication bias in meta-analyses from the Cochrane Database of Systematic Reviews","volume":"34","author":"Kicinski","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.jand.2019.05.015_bib40","series-title":"Review Manager [computer program]. Version 5.3.5","year":"2014"},{"key":"10.1016\/j.jand.2019.05.015_bib41","series-title":"R: A Language and Environment for Statistical Computing [computer program]","year":"2017"},{"key":"10.1016\/j.jand.2019.05.015_bib42","first-page":"94","article-title":"Significance of intestinal tract normal bacteria flora quantitative analysis of IBS sufferers","volume":"5","author":"Zhang","year":"2008","journal-title":"Chin Med Guides"},{"key":"10.1016\/j.jand.2019.05.015_bib43","first-page":"51","article-title":"Analysis of targeted gut microbiota inpatients with irritable bowel syndrome using 16 s rDNA qPCR","volume":"49","author":"Zhang","year":"2009","journal-title":"Shandong Med J"},{"issue":"2","key":"10.1016\/j.jand.2019.05.015_bib44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1758-2229.2012.00327.x","article-title":"Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome","volume":"4","author":"Durban","year":"2012","journal-title":"Environ Microbiol Rep"},{"key":"10.1016\/j.jand.2019.05.015_bib45","first-page":"93","article-title":"Changes of the intestinal microflora in children with irritable bowel syndrome by SYBR green 1 real time fluorescent quantitative PCR method","volume":"26","author":"Hua","year":"2014","journal-title":"Med Pharm J Chin Peoples Liberation Army"},{"issue":"3","key":"10.1016\/j.jand.2019.05.015_bib46","first-page":"364","article-title":"Dysbiosis in Ukrainian children with irritable bowel syndrome affected by natural radiation","volume":"22","author":"Sheikh Sajjadieh","year":"2012","journal-title":"Iran J Pediatr"},{"issue":"4","key":"10.1016\/j.jand.2019.05.015_bib47","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1053\/j.gastro.2017.06.004","article-title":"Intestinal fungal dysbiosis is associated with visceral hypersensitivity in patients with irritable bowel syndrome and rats","volume":"153","author":"Botschuijver","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jand.2019.05.015_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1757-4749-2-19","article-title":"Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome","volume":"2","author":"Carroll","year":"2010","journal-title":"Gut Pathog"},{"issue":"5","key":"10.1016\/j.jand.2019.05.015_bib49","doi-asserted-by":"crossref","first-page":"G799","DOI":"10.1152\/ajpgi.00154.2011","article-title":"Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome","volume":"301","author":"Carroll","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"7","key":"10.1016\/j.jand.2019.05.015_bib50","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1365-2036.2012.05007.x","article-title":"Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome","volume":"35","author":"Chassard","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jand.2019.05.015_bib51","first-page":"238","article-title":"Multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study","volume":"5","author":"Cui","year":"2012","journal-title":"Int J Clin Exp Med"},{"issue":"6","key":"10.1016\/j.jand.2019.05.015_bib52","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2982.2012.01893.x","article-title":"Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome","volume":"24","author":"Duboc","year":"2012","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"10.1016\/j.jand.2019.05.015_bib53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1572-0241.2005.40312.x","article-title":"Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR","volume":"100","author":"Malinen","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.jand.2019.05.015_bib54","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.femsim.2004.08.009","article-title":"Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome\u2014A longitudinal study in IBS and control subjects","volume":"43","author":"M\u00e4tt\u00f6","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.jand.2019.05.015_bib55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-230X-10-134","article-title":"Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota","volume":"10","author":"Noor","year":"2010","journal-title":"BMC Gastroenterol"},{"issue":"12","key":"10.1016\/j.jand.2019.05.015_bib56","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.3748\/wjg.v10.i12.1802","article-title":"Intestinal microecology and quality of life in irritable bowel syndrome patients","volume":"10","author":"Si","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jand.2019.05.015_bib57","first-page":"512","article-title":"Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome","volume":"22","author":"Tana","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.jand.2019.05.015_bib58","first-page":"633","article-title":"Analysis of patients with intestinal target bacteria diarrhea type irritable bowel syndrome","volume":"49","author":"Li","year":"2014","journal-title":"Acta Univ"},{"key":"10.1016\/j.jand.2019.05.015_bib59","first-page":"1459","article-title":"Study on the intestinal flora status of patients with different subtypes of irritable bowel syndrome","volume":"49","author":"Chen","year":"2014","journal-title":"Jiangxi Med J"},{"key":"10.1016\/j.jand.2019.05.015_bib60","first-page":"756","article-title":"Changes of intestinal flora and mast cells in patients with irritable bowel syndrome and ulcerative colitis","volume":"36","author":"Wang","year":"2015","journal-title":"Guangdong Med J"},{"key":"10.1016\/j.jand.2019.05.015_bib61","first-page":"86","article-title":"Alteration and significance ofintestinal microbiota in patients with irritable bowel syndrome","volume":"47","author":"Hu","year":"2012","journal-title":"Univ Med Anhui"},{"key":"10.1016\/j.jand.2019.05.015_bib62","first-page":"41","article-title":"Study on the microecologicalchanges and curetive effects of irritable bowel syndrome by Chinese drug \u201cShenqu","volume":"17","author":"Zhuang","year":"2005","journal-title":"Chin J Microecol"},{"issue":"1","key":"10.1016\/j.jand.2019.05.015_bib63","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000477205","article-title":"Gut microbiota in health, diverticular disease, irritable bowel syndrome, and inflammatory bowel diseases: Time for microbial marker of gastrointestinal disorders","volume":"36","author":"Lopetuso","year":"2018","journal-title":"Dig Dis"},{"issue":"1","key":"10.1016\/j.jand.2019.05.015_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jgh.13471","article-title":"Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis","volume":"32","author":"Zhuang","year":"2017","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jand.2019.05.015_bib65","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Julian","year":"2008"},{"key":"10.1016\/j.jand.2019.05.015_bib66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2288-14-30","article-title":"Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference?","volume":"14","author":"Takeshima","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jand.2019.05.015_bib67","first-page":"427","article-title":"Control study on the microecology in irritable bowel syndrome","volume":"24","author":"Yu","year":"2004","journal-title":"Chin J Digest"},{"key":"10.1016\/j.jand.2019.05.015_bib68","first-page":"164","article-title":"Intestinal flora changesin patients with irritable bowel syndrome after ingestion of Clostridium butyicum preparation","volume":"11","author":"Zhang","year":"1999","journal-title":"Chin J Microecol"},{"key":"10.1016\/j.jand.2019.05.015_bib69","first-page":"92","article-title":"Analysis of the gut microbiota and treatment of 63 cases of patients with irritable bowel syndrome","volume":"S1","author":"Li","year":"2003","journal-title":"J\u00a0Chin Physician"},{"issue":"6052","key":"10.1016\/j.jand.2019.05.015_bib70","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1208344","article-title":"Linking long-term dietary patterns with gut microbial enterotypes","volume":"334","author":"Wu","year":"2011","journal-title":"Science"},{"issue":"7402","key":"10.1016\/j.jand.2019.05.015_bib71","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsunenko","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jand.2019.05.015_bib72","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/2046-4053-2-107","article-title":"Risk of bias: A simulation study of power to detect study-level moderator effects in meta-analysis","volume":"2","author":"Hempel","year":"2013","journal-title":"Syst Rev"},{"issue":"3","key":"10.1016\/j.jand.2019.05.015_bib73","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.dld.2017.01.142","article-title":"Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis","volume":"49","author":"Liu","year":"2017","journal-title":"Dig Liver Dis"},{"issue":"10","key":"10.1016\/j.jand.2019.05.015_bib74","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1007\/s10620-015-3607-y","article-title":"Fecal microbiota in patients with irritable bowel syndrome compared with healthy controls using real-time polymerase chain reaction: An evidence of dysbiosis","volume":"60","author":"Shukla","year":"2015","journal-title":"Digest Dis Sci"},{"issue":"6","key":"10.1016\/j.jand.2019.05.015_bib75","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1365-2672.2004.02409.x","article-title":"Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR","volume":"97","author":"Rinttila","year":"2004","journal-title":"J\u00a0Appl Microbiol"},{"issue":"11-12","key":"10.1016\/j.jand.2019.05.015_bib76","first-page":"993","article-title":"Rapid and sensitive detection of Shiga toxin-producing Escherichia coli directly from stool samples by real-time PCR in comparison to culture, enzyme immunoassay and Vero cell cytotoxicity assay","volume":"57","author":"Gerritzen","year":"2011","journal-title":"Clin Lab"},{"issue":"7","key":"10.1016\/j.jand.2019.05.015_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069930","article-title":"A\u00a0re-analysis of the Cochrane Library data: The dangers of unobserved heterogeneity in meta-analyses","volume":"8","author":"Kontopantelis","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jand.2019.05.015_bib78","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychol Methods"},{"issue":"1","key":"10.1016\/j.jand.2019.05.015_bib79","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.gastro.2007.04.005","article-title":"The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects","volume":"133","author":"Kassinen","year":"2007","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jand.2019.05.015_bib80","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1053\/j.gastro.2011.06.072","article-title":"Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome","volume":"141","author":"Saulnier","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jand.2019.05.015_bib81","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1053\/j.gastro.2011.07.043","article-title":"Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome","volume":"141","author":"Rajilic-Stojanovic","year":"2011","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.jand.2019.05.015_bib82","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1136\/gutjnl-2013-305994","article-title":"Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome","volume":"63","author":"Jalanka-Tuovinen","year":"2014","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.jand.2019.05.015_bib83","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/gutjnl-2011-301501","article-title":"An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota","volume":"61","author":"Jeffery","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jand.2019.05.015_bib84","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.03.049","article-title":"Gut microbiota in patients with irritable bowel syndrome\u2014A systematic review","author":"Pittayanon","year":"2019","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.jand.2019.05.015_bib85","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/apt.13399","article-title":"The relationship between faecal-associated and mucosal-associated microbiota in irritable bowel syndrome patients and healthy subjects","volume":"42","author":"Rangel","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jand.2019.05.015_bib86","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"issue":"5728","key":"10.1016\/j.jand.2019.05.015_bib87","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1007\/s10620-018-5086-4","article-title":"Fecal and mucosa-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome","volume":"63","author":"Maharshak","year":"2018","journal-title":"Digest Dis Sci"},{"key":"10.1016\/j.jand.2019.05.015_bib88","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.coph.2018.08.011","article-title":"Mucosal permeability and mast cells as targets for functional gastrointestinal disorders","volume":"43","author":"Keita","year":"2018","journal-title":"Curr Opin Pharmacol"},{"issue":"11","key":"10.1016\/j.jand.2019.05.015_bib89","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1139\/cjm-2015-0311","article-title":"In\u00a0vitro probiotic characterization of Lactobacillus strains from fermented radish and their anti-adherence activity against enteric pathogens","volume":"61","author":"Damodharan","year":"2015","journal-title":"Can J Microbiol"},{"issue":"1","key":"10.1016\/j.jand.2019.05.015_bib90","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12929-018-0476-7","article-title":"Visceral pain: Gut microbiota, a new hope?","volume":"25","author":"Pusceddu","year":"2018","journal-title":"J\u00a0Biomed Sci"},{"issue":"10","key":"10.1016\/j.jand.2019.05.015_bib91","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/apt.15001","article-title":"Systematic review with meta-analysis: The efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","volume":"48","author":"Ford","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jand.2019.05.015_bib92","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/apt.12800","article-title":"Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain\u2014A randomised clinical study","volume":"40","author":"Ringel-Kulka","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jand.2019.05.015_bib93","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neubiorev.2017.09.016","article-title":"Do bacteria shape our development? Crosstalk between intestinal microbiota and HPA axis","volume":"83","author":"de Weerth","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"10.1016\/j.jand.2019.05.015_bib94","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.1002\/jcp.27559","article-title":"Probiotics importance and their immunomodulatory properties","volume":"234","author":"Yousefi","year":"2019","journal-title":"J\u00a0Cell Physiol"},{"issue":"1","key":"10.1016\/j.jand.2019.05.015_bib95","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/sjg.SJG_333_17","article-title":"Lactobacillus acidophilus and Bifidobacterium longum supernatants upregulate the serotonin transporter expression in intestinal epithelial cells","volume":"24","author":"Cao","year":"2018","journal-title":"Saudi J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jand.2019.05.015_bib96","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.gtc.2017.10.003","article-title":"The role of diet in the treatment of irritable bowel syndrome: A systematic review","volume":"47","author":"Singh","year":"2018","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jand.2019.05.015_bib97","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nut.2017.07.004","article-title":"Low fermentable, oligo-, di-, mono-saccharides and polyol diet in the treatment of irritable bowel syndrome: A systematic review and meta-analysis","volume":"45","author":"Schumann","year":"2018","journal-title":"Nutrition"},{"issue":"4","key":"10.1016\/j.jand.2019.05.015_bib98","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrgastro.2013.259","article-title":"Mechanisms and efficacy of dietary FODMAP restriction in IBS","volume":"11","author":"Staudacher","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.jand.2019.05.015_bib99","first-page":"1510","article-title":"Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome","volume":"142","author":"Staudacher","year":"2012","journal-title":"J\u00a0Nutr"},{"issue":"4","key":"10.1016\/j.jand.2019.05.015_bib100","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1053\/j.gastro.2017.06.010","article-title":"A\u00a0diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores Bifidobacterium species: A randomized controlled trial","volume":"153","author":"Staudacher","year":"2017","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jand.2019.05.015_bib101","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1136\/gutjnl-2015-311339","article-title":"FODMAPs alter symptoms and the metabolome of patients with IBS: A randomised controlled trial","volume":"66","author":"McIntosh","year":"2017","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jand.2019.05.015_bib102","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/apt.13286","article-title":"Randomised clinical trial: Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome","volume":"42","author":"Chumpitazi","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jand.2019.05.015_bib103","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2982.2011.01803.x","article-title":"Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome","volume":"24","author":"Parkes","year":"2012","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"10.1016\/j.jand.2019.05.015_bib104","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijfoodmicro.2011.06.003","article-title":"Metabolic activities and probiotic potential of bifidobacteria","volume":"149","author":"Russell","year":"2011","journal-title":"Int J Food Microbiol"},{"issue":"7","key":"10.1016\/j.jand.2019.05.015_bib105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201410","article-title":"A\u00a0low FODMAP diet is associated with changes in the microbiota and reduction in breath hydrogen but not colonic volume in healthy subjects","volume":"13","author":"Sloan","year":"2018","journal-title":"PLoS One"},{"issue":"36","key":"10.1016\/j.jand.2019.05.015_bib106","doi-asserted-by":"crossref","first-page":"8776","DOI":"10.1021\/jf2053959","article-title":"Up-regulating the human intestinal microbiome using whole plant foods, polyphenols, and\/or fiber","volume":"60","author":"Tuohy","year":"2012","journal-title":"J\u00a0Agric Food Chem"},{"issue":"12","key":"10.1016\/j.jand.2019.05.015_bib107","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1017\/S0007114512000281","article-title":"Wholegrain oat-based cereals have prebiotic potential and low glycaemic index","volume":"108","author":"Connolly","year":"2012","journal-title":"Br J Nutr"},{"issue":"3","key":"10.1016\/j.jand.2019.05.015_bib108","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1017\/S0029665116000021","article-title":"Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: Probiotics, prebiotics and the low FODMAP diet","volume":"75","author":"Staudacher","year":"2016","journal-title":"Proc Nutr Soc"},{"issue":"2","key":"10.1016\/j.jand.2019.05.015_bib109","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10620-017-4893-3","article-title":"Exploring gut microbiota composition as an indicator of clinical response to dietary FODMAP restriction in patients with irritable bowel syndrome","volume":"63","author":"Valeur","year":"2018","journal-title":"Digest Dis Sci"},{"issue":"5","key":"10.1016\/j.jand.2019.05.015_bib110","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/gutjnl-2016-313128","article-title":"Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs","volume":"67","author":"Bennet","year":"2018","journal-title":"Gut"}],"container-title":["Journal of the Academy of Nutrition and Dietetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212267219304721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212267219304721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:28:58Z","timestamp":1761942538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212267219304721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2212267219304721"],"URL":"https:\/\/doi.org\/10.1016\/j.jand.2019.05.015","relation":{},"ISSN":["2212-2672"],"issn-type":[{"value":"2212-2672","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies","name":"articletitle","label":"Article Title"},{"value":"Journal of the Academy of Nutrition and Dietetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jand.2019.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the Academy of Nutrition and Dietetics.","name":"copyright","label":"Copyright"}]}}